Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This clinical trial is designed to study the effect and safety of paclitaxel plus cisplatin
as the first-line regimen in the treatment of high risk gestational trophoblastic tumor.
Phase:
Phase 3
Details
Lead Sponsor:
Weiguo Lv
Collaborators:
First Affiliated Hospital of Zhongshan Medical University Huazhong University of Science and Technology Shandong University